The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCharacter Regulatory News (CCT)

Share Price Information for Character (CCT)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 277.00
Bid: 274.00
Ask: 280.00
Change: 0.00 (0.00%)
Spread: 6.00 (2.19%)
Open: 277.00
High: 278.00
Low: 277.00
Prev. Close: 277.00
CCT Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Transaction in Own Shares

29 Jan 2015 16:02

RNS Number : 5382D
Character Group PLC
29 January 2015
 

29 January 2015

The Character Group plc

("Character Group" or the "Company")

 

Director's share dealing

Transaction in Own Shares

 

 

Character Group (AIM:CCT.L) announces that the Company has bought back for cancellation 125,000 ordinary shares of 5p each in the capital of the Company ("Ordinary Shares") in the market, at a price of 365p pence per ordinary share.

 

The Company is continuing its programme of buying back shares for cancellation and announces that on 28 January 2015 it acquired 25,000 Ordinary Shares through open market purchases, representing approximately 0.12 per cent of the issued share capital of the Company (excluding shares held in Treasury).

 

The Company also purchased 100,000 Ordinary Shares on 29 January 2015 from Richard King, Executive Chairman. This represents approximately 0.47 per cent. of the Company's issued share capital. Following the share sale Mr King's interest in the Company is 2,318,210 Ordinary Shares representing approximately 10.87 per cent. of the total voting rights of the Company. 

 

The participation by Mr King in the buy-back programme is deemed to be a related party transaction for the purposes of Rule 13 of the AIM Rules for Companies. The Independent Directors of the Company, who are independent of this deemed related party transaction for the purposes of the AIM Rules, having consulted with Charles Stanley Securities (the Company's Nominated Adviser), consider the participation of Mr King in the buy-back programme to be fair and reasonable insofar as the Company's shareholders are concerned.

 

For the purposes of the Financial Conduct Authority's Disclosure and Transparency Rules, the total number of Ordinary Shares in issue as at the date of this announcement (taking into account the Ordinary Shares purchased for cancellation by the Company announced above and excluding Ordinary Shares held in Treasury) is 21,324,914 ("Revised Issued Voting Share Capital"). The Company holds 4,019,456 Ordinary Shares in treasury, representing approximately 18.85 per cent. of the Revised Issued Voting Share Capital, which do not carry voting rights.

 

The Company has a total unutilised capacity to buy back up to a further 5,145,500 Ordinary Shares under the authority granted at the Annual General Meeting on 16 January 2015.

 

The figure of 21,324,914 may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest, or change to their interest, in the Company under the Disclosure and Transparency Rules.

 

 

Enquiries:

 

 

Richard King, Chairman

Kiran Shah, Group Finance Director & Joint MD

Mark Dowding, Company Secretary

Fiona Tooley

Russell Cook

Carl Holmes

 

 

 

The Character Group plc

Tooley Street Communications

Charles Stanley Securities

 

IR & Media Relations

Nominated Adviser and Broker

Tel: +44 (0)208 329 3377

Tel: +44 (0)7785 703 523

Tel: +44 (0)207 149 6000

 

 

 

Ticker: AIM: CCT

 

 

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
POSLLFIRLLIAFIE
Date   Source Headline
29th Apr 20245:47 pmRNSTransaction in Own Shares
26th Apr 20247:00 amRNSHolding(s) in Company
12th Apr 20246:16 pmRNSTransaction in Own Shares
11th Apr 20245:23 pmRNSTransaction in Own Shares
9th Apr 20245:25 pmRNSTransaction in Own Shares
8th Apr 20245:49 pmRNSTransaction in Own Shares
4th Apr 20245:44 pmRNSTransaction in Own Shares
3rd Apr 20247:00 amRNSExtension of & increase to Share Buyback Programme
13th Mar 20245:19 pmRNSTransaction in Own Shares
7th Mar 20245:55 pmRNSTransaction in Own Shares
5th Mar 20247:00 amRNSTransaction in Own Shares
1st Mar 20245:03 pmRNSTransaction in Own Shares
27th Feb 20245:03 pmRNSTransaction in Own Shares
27th Feb 20247:00 amRNSTransaction in Own Shares
23rd Feb 20245:20 pmRNSTransaction in Own Shares
22nd Feb 20245:59 pmRNSTransaction in Own Shares
21st Feb 20245:03 pmRNSTransaction in Own Shares
19th Feb 20246:08 pmRNSTransaction in Own Shares
19th Feb 202412:07 pmRNSHolding(s) in Company
19th Feb 20247:00 amRNSTransaction in Own Shares
15th Feb 20246:13 pmRNSTransaction in Own Shares
14th Feb 20245:38 pmRNSTransaction in Own Shares
13th Feb 20245:49 pmRNSTransaction in Own Shares
9th Feb 20244:19 pmRNSTransaction in Own Shares
8th Feb 20245:44 pmRNSTransaction in Own Shares
7th Feb 202410:20 amRNSTransaction in Own Shares
6th Feb 20247:00 amRNSShare Buyback Programme
19th Jan 20244:41 pmRNSResult of AGM
19th Jan 20247:00 amRNSAGM Statement - Trading Update
14th Dec 202312:53 pmRNSHolding(s) in Company
14th Dec 202312:49 pmRNSHolding(s) in Company
12th Dec 20237:01 amRNSFinal Results - year ended 31 August 2023
12th Dec 20237:00 amRNSBoard Changes
23rd Oct 20234:58 pmRNSDirector/PDMR Shareholding
3rd Oct 20237:00 amRNSTrading Update
22nd Sep 20234:08 pmRNSHolding(s) in Company
20th Sep 20235:30 pmRNSHolding(s) in Company
22nd Aug 20237:00 amRNSHolding(s) in Company
31st Jul 20237:00 amRNSDirector/PDMR Shareholding
17th May 202311:32 amRNSDirector/PDMR Shareholding
15th May 20237:00 amRNSDirector/PDMR Shareholding
15th May 20237:00 amRNSHolding(s) in Company
11th May 20237:00 amRNSHalf-year Report - six months to 28 February 2023
27th Mar 20236:00 pmRNSHolding(s) in Company
20th Jan 20234:41 pmRNSResult of AGM
20th Jan 20237:00 amRNSTrading update ahead of the AGM
28th Dec 20227:34 amRNSDirector's share dealings, Treasury shares and TVR
22nd Dec 20224:40 pmRNSSecond Price Monitoring Extn
22nd Dec 20224:35 pmRNSPrice Monitoring Extension
22nd Dec 20227:00 amRNSAUDITED ANNUAL RESULTS -YEAR ENDED 31 AUGUST 2022

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.